| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Institute of Nephrology,*
University of Wales
College of Medicine, Heath Park, Cardiff, Wales, United Kingdom; and
the Laboratory of Cell Regulation and
Carcinogenesis,
National Cancer Institute,
Bethesda, Maryland
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Transforming growth factor-ß1 (TGF-ß1) has emerged as a mediator that is implicated in the pathogenesis of fibrosis in both glomerular and interstitial compartments of the kidney and has been particularly associated with diabetic nephropathy.4 It is now clear that PTCs have the potential to contribute to the pathogenesis of renal fibrosis by the production of profibrotic growth factors, including TGF-ß1.5-7 We have previously demonstrated that TGF-ß1 production in PTCs may be controlled at the levels of transcription, translation, and secretion of preformed protein as well as at the level of activation of the latent protein.5-8 In the context of diabetic nephropathy we have demonstrated that the synergistic action of elevated concentrations of glucose and cytokines such as platelet-derived growth factor or interleukin-1ß stimulate PTC TGF-ß1 synthesis.5,6 This induction of TGF-ß1 synthesis resulted from translation of glucose-induced TGF-ß1 mRNA by either cytokine, and was associated with an alteration in its inherent stability.
Despite the large amount of research into the etiology of renal disease in diabetes mellitus, little is known regarding the relationship between insulin and levels of glycemia in the context of tissue damage. Insulin plays an important role in the overall regulation of protein synthesis. Not only does it cause a global increase in the rate of translation, but it may also bring about marked increases in the translation of specific mRNAs. The aim of this study was therefore to examine the effect of insulin on the synthesis of TGF-ß1 by PTCs. In this manuscript we present evidence that insulin specifically stimulates translation of TGF-ß1 mRNA, via an interaction with the insulin-like growth factor-1 (IGF-1) receptor. In addition we examine the possible mechanisms involved in mediating these effects of insulin.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
All experiments were performed using HK-2 cells, which are human renal proximal tubular epithelial cells immortalized by transduction with human papilloma virus 16 E6/E7 genes.9 Cells were cultured in Dulbecco’s modified Eagle’s medium/Ham’s F12 (Life Technologies, Paisley, UK) supplemented with 10% fetal calf serum (Biological Industries Ltd., Cumbernauld, UK), glutamine (Life Technologies Ltd., Paisley, UK), transferrin, and sodium selenite (Sigma, Poole, UK). Fresh growth medium was added to cells every 3 to 4 days until confluent. Cells were grown to confluence and growth arrested in serum-free medium for 48 hours. All experiments were subsequently performed under serum-free conditions.
TGF-ß1 Protein Quantification
Growth-arrested HK-2 cells were stimulated with insulin (5 µg/ml, Sigma), and supernatant samples collected throughout the subsequent 48 hours. Samples were stored at -70°C before quantification of both TGF-ß1 and TGF-ß2. In all experiments TGF-ß1 protein concentration in the cell culture supernatant was determined by specific enzyme-linked immunosorbent assay (ELISA) (Amersham Pharmacia Biotech Ltd., Little Chalfont, UK). The assay is sensitive to 4 pg/ml, with no cross-reactivity with either TGF-ß2 or TGF-ß3 isoforms. TGF-ß1 was only detected after acidification of the samples indicating that TGF-ß1 was produced in its latent form. In the same samples TGF-ß2 also quantified by specific ELISA (Quantikine human TGF-ß1 ELISA; R&D Systems, Abingdon, UK). The assay is sensitive to 7 pg/ml, with no cross-reactivity with other TGF-ß isoforms. TGF-ß2 was only detected after acidification of the samples indicating that TGF-ß2 was produced in its latent form. In all experiments after removal of the supernatant, cell protein content was determined using a modified Bradford assay,10 and TGF-ß (1 + 2) concentrations were corrected for total cell protein concentration.
To further examine TGF-ß1 synthesis, we examined radioactive amino acid incorporation into TGF-ß1 in the presence of insulin. Four µCi of 3H-radiolabeled amino acid mixture (20 µCi/ml; Amersham) was added to growth-arrested confluent cells in the presence of insulin (5 µg/ml) for a total of 48 hours. Supernatant samples were subsequently collected for TGF-ß1 immunoprecipitation. Before immunoprecipitation supernatant samples (400 µl) were precleared with 25 µl of agarose-protein A beads (Sigma) at 4°C for 1 hour with constant mixing. The beads were removed by centrifugation and the supernatant decanted. Forty µg of polyclonal rabbit anti-human TGF-ß1 antibody (Santa Cruz, Autogen Bioclear UK Ltd., Calne, UK) was added to each 400 µl of cleared supernatant and incubated at 4°C with constant mixing for 12 hours. Subsequently 25 µl of agarose beads were added to capture the immune complexes. Separation of the beads was achieved by centrifugation (13,000 x g for 5 minutes) and the supernatant discarded. Twenty-five µl of sodium dodecyl sulfate (SDS) sample buffer was added to each preparation and boiled for 3 minutes at 95°C, which was subsequently run on a 10% SDS-polyacrylamide gel electrophoresis (PAGE). Gels were fixed by incubating in acetic acid/methanol/H20 (1:4:5 by volume) overnight. Finally the gels were soaked in Amplify scintillant (Amersham, Life Science) for 30 minutes and the gels dried before visualization of immunoprecipitated TGF-ß1 by autoradiography. Efficiency of immunoprecipitation was confirmed by a second immunoprecipitation of the original supernatant with the primary antibody.
TGF-ß1 Gene Expression: Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) and Northern Analysis
After stimulation of confluent growth-arrested HK-2 cells with
insulin (5 µg/ml) for up to 48 hours, total cellular RNA was isolated
and TGF-ß1 mRNA examined by RT, and PCR amplification was performed
using specific oligonucleotide primers (Table 1)
as previously described.5
PCR was performed for various cycles (28 to 40), to ensure that
amplification was in the linear range of the curve. One-tenth of the
PCR reaction from both test and control (
-actin) product were mixed
and separated by flat bed electrophoresis in 3% w/v NuSieve GTG
agarose gels (Flowgen Instruments Ltd., Sittingbourne, UK), stained
with ethidium bromide (Sigma) and photographed. The negatives were
scanned using a densitometer (model 620 video densitometer; Bio-Rad
Laboratories Ltd., Menelhempstead, UK) and the density of the bands
compared to those of the housekeeping gene -actin.
|
Transcription/Translation/mRNA Stability
To further investigate the mechanism of insulin-induced TGF-ß1 synthesis, HK-2 cells were stimulated with insulin in the presence of increasing doses of either actinomycin D (0 to 0.5 µg/ml) to inhibit de novo gene transcription or cycloheximide (0 to 5 µg/ml) to inhibit mRNA translation, respectively. Toxicity of actinomycin D and cycloheximide was assessed using cellular ATP measurements. Only doses that did not lead to a reduction in cellular ATP were used. We have previously demonstrated inhibition of gene expression by actinomycin and inhibition of translation by cycloheximide over these dose ranges.5,6 Actinomycin D or cycloheximide was added to growth-arrested HK-2 cells for 1 hour before stimulation with insulin, and supernatant samples were collected throughout the subsequent 48 hours for quantitation of TGF-ß1 by ELISA.
The rate of degradation of TGF-ß1 mRNA after the addition of actinomycin D was used to assess the effect of insulin on inherent stability of constitutively expressed TGF-ß1 mRNA in HK-2 cells.11 Toxicity of actinomycin D was assessed using cellular ATP measurements, and the maximal nontoxic dose was used (0.5 µg/ml).5 Growth-arrested HK-2 cells were incubated with actinomycin D (0.5 µg/ml) for 1 hour before the addition of insulin. In control experiments 5 mmol/L of D-glucose in the absence of insulin was added to actinomycin D-treated cells. The rate of mRNA degradation was determined by isolating total RNA from these cells at various times up to 24 hours after the addition of actinomycin D and performing RT-PCR.
Gel Retardation Analysis
Confluent HK-2 cell monolayers were stimulated with insulin (5 µg/ml) for 48 hours and cytoplasmic proteins were prepared as previously described.12 Briefly after detachment and washing of the cell pellet with phosphate-buffered saline at 4°C, cells were treated with a nondisruptive buffer (10 mmol/L KCl, 10 mmol/L Hepes, pH 7.9, 1.5 mmol/L MgCl2, 10 mmol/L NaF, 0.5 mmol/L dithiothreitol, 100 µmol/L sodium orthovanadate, 25 mmol/L ß-glycerophosphate, 0.2% (v/v) Nonidet P-40, and a cocktail of protease inhibitors) and incubated on ice for a further 10 minutes. Subsequently to remove debris and nuclei, the lysate was centrifuged for 10 minutes at 10,000 x g at 4°C. The supernatant (cytoplasmic extract) was collected and its protein content determined using a modified Bradford assay.10 Aliquots were frozen at -70°C.
A fragment of the TGF-ß1 5'-UTR corresponding to bases +1 to +147, was inserted into the HindIII and XbaI sites of the pGEM4 (Promega, Southhampton, UK) and radiolabeled probes for gel retardation analysis generated as previously described.12 The probes (1.5 x cpm) were incubated for 30 minutes at room temperature with the cytoplasmic extract (20 µg) in a total volume of 15 µl containing 10 mmol/L Tris-HCl, pH 7.5, 100 mmol/L NaCl, 5 mmol/L dithiothreitol, 4% glycerol, 1 mmol/L ethylenediaminetetraacetic acid, and 0.1 mg/ml nuclease-free bovine serum albumin. To ensure that proteins did not bind nonspecifically to the target RNA, 1.5 µl of the synthetic polymer poly (dl-dC)-poly (dl-dC) (Pharmacia Biotech) was added to the final mixture. Complexes were resolved from the free probe by electrophoresis through 6% nondenaturing polyacrylamide gel and visualized by autoradiography.
Role of Insulin versus IGF Receptors
To determine whether the effects of insulin were mediated via binding to its own receptor or via the IGF receptor, three approaches were used. 1) Cells were stimulated with insulin over a range of insulin concentrations that would lead to interaction primarily with the insulin receptor (0 to 500 ng/ml). 2) At the higher dose (5 µg/ml), which led to alterations in TGF-ß1 generation, the role of the IGF-1 receptor in mediating these effects was determined by stimulating cells with insulin in the presence of a monoclonal anti-human IGF-1R-blocking antibody (R&D Systems). 3) Finally, cells were stimulated with recombinant IGF-1 (R&D Systems), to determine whether the effect of insulin could be mimicked by IGF-1 over a dose range that would lead to it interacting primarily with the IGF-1 receptor. In all experiments supernatant samples were collected at time points up to 48 hours, and stored at -70°C before quantification of TGF-ß1.
Signaling Pathways
Involvement of the MAP/ERK kinase, PI 3 kinase, and p70 S6 kinase in insulin-induced TGF-ß1 stimulation, was examined by stimulation of growth-arrested cells with insulin (5 µg/ml) in the presence of either PD 98059 (2 µmol/L), wortmannin (10 nmol/L), or rapamycin (30 nmol/L), which are specific inhibitors of each of these kinases. That the inhibitors did not influence cell viability was confirmed, as cellular ATP was not affected by the addition of each of the inhibitors. All inhibitors were obtained from Calbiochem (Nottingham, UK) and the dose was derived from their known IC50, and their previously published effects in proximal tubular cells.13 In all experiments the inhibitor was added for 20 minutes before the addition of insulin in the presence of the inhibitor. Supernatant samples were collected at time points up to 48 hours and stored at -70°C before quantification of TGF-ß1.
Functional Significance of Increased TGF-ß1 Synthesis
Analysis of alteration in collagen IV concentration in the extracellular matrix was examined by Western analysis. Briefly cells were stimulated with insulin (5 µg/ml) for 48 hours under serum-free conditions in the presence or absence of a TGF-ß-blocking antibody (Genzyme Diagnostics, Cambridge MA). After detachment of the cell monolayer by the addition of 0.02% ethylenediaminetetraacetic acid, the extracellular matrix laid down by the cells was extracted by the addition of 4 mol/L guanidine hydrochloride-2% Triton X-100 in 25 mmol/L of Tris/HCl in the presence of the protease inhibitors benzamidine, n-ethylmaliamide, phenylmethyl sulfonyl fluoride, and e-amino-n-caproic acid. Matrix samples were subsequently prepared in SDS sample buffer and boiled for 3 minutes at 95°C. Equal amounts of total protein were loaded onto 3 to 12% SDS-PAGE gradient gels and electrophoresis was performed under reducing conditions according to the procedure of Laemmli.14 After electrophoresis the separated proteins were transferred to a nitrocellulose membrane (Amersham, Little Chalfont, UK). The membrane was blocked with Tris-buffered saline containing 5% nonfat powdered milk for 1 hour and then incubated with the primary antibody (goat polyclonal anti-collagen type IV; ICN Pharmaceuticals, Inc., Baisingstoke, UK) in Tris-buffered saline containing 1% bovine serum albumin and 0.05% Tween 20 (Tris-buffered saline-Tween) for 1 hour at room temperature. The blots were subsequently washed in Tris-buffered saline-Tween and then incubated with an appropriate horseradish peroxidase-conjugated secondary antibody (Sigma) in Tris-buffered saline-Tween. Proteins were visualized using enhanced chemiluminescence (Amersham) according to the manufacturer’s instructions. By Western analysis, the higher molecular weight band represents intact collagen whereas the lower molecular weight bands demonstrate its partial degradation.
Gelatinase activity in cell culture supernatant was determined by zymography. Samples were run at 4°C on 7.5% nonreducing SDS-polyacrylamide gels containing gelatin at a final concentration of 1 mg/ml at 4°C. The gels were then washed in 2.5% Triton at room temperature for 1 hour, before incubation overnight at 37°C in 50 mmol/L of Tris-HCl, pH 7.6, containing 10 mmol/L of CaCl2 and 0.05% Brij. The presence of gelatinase activity was demonstrated by zones of lysis in the Coomassie Blue-stained gel.15
Statistics
Statistical analysis was performed using the unpaired Student’s t-test, with a value of P < 0.05 considered to represent a significant difference. The data are presented as means ± SD of n experiments. For each individual experiment the mean of duplicate determinations was calculated.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Addition of insulin to growth-arrested HK-2 cells led to an
increase in TGF-ß1 concentration in the cell culture medium (Figure 1)
. This effect was significant 24 hours
after the addition of insulin (655.2 ± 12.8 pg/ng cell protein
versus 445.9 ± 10.6 pg/ng cell protein, insulin
versus control, mean ± SD, n = 8,
P = 0.003). Despite an increase in TGF-ß1 generated
after the addition of insulin, no alteration in the expression of
TGF-ß1 mRNA was seen, as assessed by either RT-PCR or Northern
analysis (Figure 2)
. Northern analysis
however confirmed constitutive expression of a single 2.5-kb TGF-ß1
transcript. Autoradiography of immunoprecipitated TGF-ß1 after
stimulation by insulin in the presence of radiolabeled amino acids
demonstrated increased incorporation of radiolabel into TGF-ß1 thus
confirming stimulation of de novo TGF-ß1 synthesis by
insulin (Figure 3)
.
|
|
|
The effect of insulin on the generation of TGF-ß1 was specific in that addition of insulin did not stimulate TGF-ß2 generation (1097.5 ± 235 pg/ng cell protein versus 839.9 ± 313.4 pg/ng cell protein, control versus insulin stimulated, mean ± SD, n = 8, P = 0.08). The lack of induction of TGF-ß2 in response to insulin was apparent for both 5 mmol/L and 25 mmol/L of D-glucose-pretreated cells (data not shown).
TGF-ß1 Synthesis Is Dependent on mRNA Translation
Inhibition of de novo gene transcription by the
addition of actinomycin D before addition of insulin in HK-2 cells had
no effect on insulin-induced TGF-ß1 generation (Figure 4A)
. In contrast inhibition of mRNA
translation and protein synthesis by addition of cycloheximide (Figure 4B)
led to a dose-dependent decrease in TGF-ß1 generation after the
addition of insulin ]764.2 ± 316.5 pg/ng cell protein
versus 338.2 ± 96.8 pg/ng cell protein control
versus cycloheximide (5 µg/ml), mean ± SD,
n = 8, P = 0.02].
|
We have previously demonstrated in glucose-primed cells that
stimuli that induce TGF-ß1 translation may do so by mechanisms that
influence the stability of glucose-induced TGF-ß1 mRNA. In contrast
in the current study, results of actinomycin D chase experiments
demonstrate that addition of insulin did not affect the stability of
constitutively expressed TGF-ß1 mRNA (Figure 5)
.
|
Proteins that bind to the 5'-UTR of a mRNA can also regulate
translation. Furthermore binding of a cytoplasmic factor to a putative
stem loop structure in the 5' UTR of TGF-ß1 has been demonstrated to
regulate TGF-ß1 translation. Protein binding to this region (bases +1
to +147) was therefore investigated by gel retardation analysis. When a
radiolabeled probe transcribed from this fragment was incubated with
HK-2 cytoplasmic extract derived from cells stimulated with insulin,
the mobility of the probe was reduced, indicating that a factor in the
extract formed a complex with the probe (Figure 6)
. This second band was not seen when
the probe was incubated with cytoplasmic extract derived from HK-2
cells to which 5 mmol/L of D-glucose was added in the
absence of insulin. Specificity of probe binding was confirmed by
competition with unlabeled probe added to the binding reaction. Under
these conditions formation of the complex was abolished.
|
Addition of insulin at doses <1 µg/ml had no effect on the
generation of TGF-ß1 (Figure 7A)
. The
effect of insulin at the higher doses (1 to 5 µg/ml) was however
inhibited in a dose-dependent manner by the addition of a monoclonal
antibody blocking ligand binding to the IGF-1 receptor (Figure 7B)
.
Addition of recombinant IGF-1 mimicked the effect of addition of the
high dose of insulin leading to a dose-dependent increase in TGF-ß1
generation. This was also inhibited by the addition of a monoclonal
antibody to the IGF-1 receptor (Figure 8)
.
|
|
Induction of TGF-ß1 by insulin was inhibited by the addition of
the PI 3-kinase inhibitor wortmannin (Figure 9)
. Significant inhibition of insulin (5
µg/ml) induced TGF-ß1 production was seen with 10 nmol/L of
wortmannin after 48 hours [482.4 ± 131.1 pg/ng cell protein
versus 655.2 ± 12.8 pg/ng cell protein, insulin plus
wortmannin (n = 5) versus insulin
(n = 8), mean ± SD, P =
0.03]. Similarly significant inhibition of insulin-induced TGF-ß1
generation was also seen after inhibition of p70 S6 kinase by the
addition of 30 nmol/L of rapamycin [487.4 ± 57.7 pg/ng cell
protein versus 655.2 ± 12.8 pg/ng cell protein,
insulin plus rapamycin (n = 8) versus
insulin (n = 8), mean ± SD,
P = 0.0003]. Inhibition of TGF-ß1 protein synthesis
by either wortmannin or rapamycin was also associated with inhibition
of binding of insulin-induced cytoplasmic protein to the probe spanning
the sequences base +1 to +147 of the 5'-UTR of TGF-ß1 (Figure 10)
. In contrast inhibition of MAP/ERK
kinase by the addition of PD 98059 (2 µmol/L) had no effect on
insulin-induced TGF-ß1 generation [711.5 ± 27.6 pg/ng cell
protein versus 655.2 ± 12.8 pg/ng cell protein,
insulin plus PD 98059 (n = 4) versus
insulin (n = 8), mean ± SD,
P = 0.4).
|
|
To determine the functional importance of altered TGF-ß1
synthesis in response to insulin, we examined the effect of insulin on
collagen generation and its dependence on TGF-ß1. Stimulation of
cells with insulin led to increased expression of type IV collagen mRNA
(1) and increased deposition in the extracellular matrix laid down
by the cells (Figure 11)
. Addition of
insulin also led to an increase in gelatinase activity, seen
predominantly as increased gelatinolytic activity at a molecular weight
corresponding to 95-kd gelatinase B/MMP9. Stimulation of cells with
insulin in the presence of the TGF-ß-blocking antibody abrogated the
increased gelatinase activity (Figure 12)
. Because of this inhibition of
gelatinase activity, total type IV collagen concentration in the cell
culture supernatant was not affected by this TGF-ß-blocking antibody
(Figure 12)
.
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Although it is clear that hyperglycemia is an important factor in the initiation of renal disease in diabetes because only 40% of diabetic patients develop nephropathy, other factors must play an important part in both initiating and perpetuating renal injury. Despite the large body of research into the pathogenesis of diabetic nephropathy little is know regarding the effect of insulin. Hyperinsulinemia is a feature of type 2/non-insulin-dependent diabetes, and furthermore insulin therapy in type 1/insulin-dependent diabetes is also associated with periods of hyperinsulinemia. Insulin plays an important role in the overall regulation of protein synthesis and may specifically influence mRNA translation. Not only does it cause a global increase in the rate of translation, but, superimposed on this it also brings about marked increases in the translation of specific mRNAs.16 The data presented in the current article demonstrate that insulin stimulated the de novo synthesis of TGF-ß1. Furthermore we have shown that this increase in TGF-ß1 synthesis was not associated with induction of TGF-ß1 mRNA, and did not require de novo gene transcription because it was unaffected by actinomycin; rather, stimulation of TGF-ß1 synthesis in PTCs after addition of insulin involved stimulation of translation of TGF-ß1 mRNA. The potential functional importance of increased TGF-ß1 synthesis was illustrated by the associated alteration in extracellular matrix turnover that was antagonized by inhibition of TGF-ß activity.
The data also demonstrate that the effect of insulin was specific because the addition of insulin did not stimulate the production of TGF-ß2. The mRNA coding for TGF-ß1 contains an unusually long 5'-UTR that is highly rich in GC content.17 In other systems these sequences tend to be highly structured and are thought to inhibit translation. In contrast to TGF-ß1, the long 5'-UTR of TGF-ß2 does not have such a high GC content,18 and is therefore not subject to the same posttranscriptional influences.
Three transcripts have been reported for TGF-ß1 (2.5, 1.9, and 1.4 kb) that differ in the length of their GC-rich 5'-UTR.19-21 In other systems 5'-UTR with a rich GC content tend to be highly structured and are thought to inhibit translation by impeding the progress of the 40S-scanning ribosomal subunit toward the initiation codon. It is thought that translation of the truncated TGF-ß1 transcripts may therefore be more efficient owing to the deletion of inhibitory elements in the 5' leader sequence. We show that PTCs only express the poorly translated 2.5-kb transcript, and furthermore its expression was not affected by the addition of insulin. Elements spanning bases +1 to +147 5'-UTR of TGF-ß1 mRNA have previously been shown to be involved in the inhibition of TGF-ß1 translation although the inhibitory effect of this fragment is cell-type-dependent.22 It has been suggested that a cytosolic factor may regulate TGF-ß1 mRNA translation by binding to these elements.12 Most recently is has been postulated that the poor translational efficiency of the 2.5-kd TGF-ß1 mRNA in vivo may be because of a combination of poor initiation sequence context, and inhibitory interactions of limiting trans-acting factors with cis-inhibitory elements in an otherwise stimulatory 5'-UTR.23 In contrast we have identified a possible stimulatory trans-acting factor binding a portion of the 5'-UTR mRNA spanning sequences +1 to +147 previously identified as an inhibitory element.
We have previously demonstrated that TGF-ß1 production in PTCs may be controlled at the levels of transcription, translation, and secretion of preformed protein, as well as at the level of activation of the latent protein. These studies suggest that alteration of TGF-ß1 mRNA stability may be involved in facilitation of glucose-induced mRNA translation when cells were pretreated with glucose before the addition of a second stimulus such as the proinflammatory cytokine interleukin-1ß that facilitates mRNA translation.6 Increased TGF-ß1 mRNA is not however universally associated with facilitation of its translation. In fact under certain circumstances stabilization of TGF-ß1 is associated with an inhibitory influence on its translation.12 In the current article we have demonstrated that insulin-induced TGF-ß1 mRNA translation was not associated with alteration in its stability. This suggests that numerous independent and stimulus-specific mechanisms influence TGF-ß1 mRNA translation.
Insulin interacts, albeit with different affinities with both the insulin and the IGF-1 receptor. The receptors for insulin and IGF-1 are also structurally related and highly homologous, and not surprisingly the signaling mechanisms of these receptors are also broadly similar.24,25 The insulin receptor demonstrates high-affinity binding to insulin and lower affinity binding to IGF-1, whereas the IGF-1 receptor binds IGF-1 (and IGF-2) with a higher affinity than it does insulin.25 Thus at low concentrations insulin will interact primarily with the insulin receptor, but at higher concentrations, such as those used in our experiments, the insulin may interact with either receptor. We have demonstrated that the effects of insulin at our hyperinsulinemic concentrations are likely to be mediated via binding to the IGF-1 receptor, in that we could mimic the effect of insulin by the addition of recombinant IGF-1 and antagonize the effects of insulin by blockade of the IGF-1 receptor. Although the effects of insulin were mimicked by addition of recombinant IGF-1, the significance of IGF-1 as a stimulus for renal TGF-ß1 synthesis in the context of progressive diabetic nephropathy is unclear. Studies of circulating IGF-1 levels in patients with diabetes are conflicting, in part because of problems with assay methodologies. Studies with the greatest number of patients however have demonstrated decreased IGF-1 levels (50 to 90% of normal) in patients with both type 1 and type 2 diabetes.26 That IGF-1 is not involved in the progression of nephropathy is also supported by data from the streptozotocin-induced diabetes that demonstrates that the rapid increase in renal growth seen in this mode, is preceded by a rise in renal tissue expression of IGF-1 related to alteration in renal IGF receptors rather that an alteration in local IGF-1 production. This increase in renal IGF-1 however returns to normal 4 days after the induction of diabetes.27 Although we cannot rule out a role for IGF-1 in modulation of TGF-ß1 synthesis in diabetic nephropathy, it is likely that insulin/hyperinsulinemia via IGF-1 receptor signaling modulates renal TGF-ß1 in diabetes.
The renal proximal tubular cell is a bipolar epithelial cell. Its plasma membrane is differentiated into a basolateral portion that is in contact with the peritubular circulation and a brush border portion that is bathed in glomerular ultrafiltrate. Previously we have demonstrated that induction of TGF-ß1 synthesis after sequential stimulation with glucose and cytokines was a polar phenomenon. Induction of TGF-ß1 only occurred after application of glucose to the basal aspect of the cell, and similarly stimulation of TGF-ß1 synthesis was only seen after addition of cytokines also to the basolateral cell surface.8 It is known that the IGF-1 receptor has an asymmetric distribution, being present primarily on the basolateral cell surface.28 The actions of IGF-1 on TGF-ß1 synthesis in the proximal tubule, like those of glucose and cytokines, are therefore likely to be mediated via interaction of circulating peptide with specific receptors on the basolateral membrane.
Many similarities exist in the postreceptor signaling pathways between the insulin and the IGF receptor. The effects of these ligands are initiated by their binding to the extracellular domain of the receptors and subsequent activation of intracellular tyrosine kinase activity. This leads to autophosphorylation of the receptor and activation of Ras and phosphatidylinositol-3-kinase and hence to the activation of a number of serine/threonine protein kinases activating the mitogen-activated kinase (MAP/ERK kinase) cascade, protein kinase B (PKB) and the activation of the 70-kd ribosomal S6 protein kinase (p70 S6 kinase). Previous studies with insulin have demonstrated that alteration in signaling via each of these pathways may influence protein translation by their regulation of eukaryotic initiation factors (eIFs), and elongation factors (eEFs).16,29,30 Our data demonstrate that the effect of insulin on TGF-ß1 synthesis was mediated via the PI-3 kinase-p70 S6 kinase cascade because it was inhibited by both rapamycin and wortmannin, but not inhibited by inhibition of MAPK/Erk kinase. Studies to date have demonstrated that the acute effects of insulin and growth factors on protein synthesis are achieved by regulating the function of multiple components of the initiation and elongation complexes involved in mRNA translation. The eukaryotic initiation factor 2b (eIF2b) is phosphorylated in response to insulin by a pathway involving PI 3-kinase.31 An insulin-induced reduction in phosphorylation of eukaryotic elongation factor-2 (eEF2) is associated with an increase in translation, and both rapamycin and wortmannin block this effect.32 These inhibitors also inhibit insulin-stimulated phosphorylation of the eukaryotic initiation factor 4E (eIF-4E)-binding protein (4EBP-1).33,34 These known effects of insulin and the pattern of inhibition of insulin-stimulated TGF-ß1 synthesis that we have demonstrated suggests that these initiation and elongation factors may be involved in facilitation of translation of TGF-ß1 and may represent useful avenues for future studies to identify the cytoplasmic factors that affect this process.
It is well recognized that the control of TGF-ß1 bioactivity is complex, and that independent regulatory mechanisms may influence transcription, translation, secretion, activation, and postreceptor signaling events. The data in the current article further emphasized the complexity of control of TGF-ß1 synthesis. Together with previously published studies it is now clear that numerous different stimulus-specific mechanisms influence TGF-ß1 translation. We have also demonstrated that in diabetes numerous mechanisms exist that may alter the generation of TGF-ß1 by the proximal tubular epithelial cell. Furthermore the data demonstrate that insulin stimulates TGF-ß1-mediated alterations in extracellular matrix turnover suggesting that insulin and hyperinsulinemia may therefore influence the pathological changes in the renal interstitium associated with this condition.
|
Footnotes |
|---|
Supported by the British Diabetic Association (to K. M.), the National Kidney Research Fund (to R. E.) and by an Advanced Training Fellowship from the Wellcome Trust (to A. P.).
Accepted for publication July 30, 2001.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
. Kidney Int 1996, 50:1546-1554[Medline]
This article has been cited by other articles:
 |
|
 |
|
  M. Ponticos, C. Harvey, T. Ikeda, D. Abraham, and G. Bou-Gharios JunB mediates enhancer/promoter activity of COL1A2 following TGF-{beta} induction Nucleic Acids Res., June 26, 2009; (2009) gkp544v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhang, C.-H. Lee, D. D. Luo, A. Krupa, D. Fraser, and A. Phillips Polarity of Response to Transforming Growth Factor-beta1 in Proximal Tubular Epithelial Cells Is Regulated by beta-Catenin J. Biol. Chem., September 28, 2007; 282(39): 28639 - 28647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhang, D. Fraser, and A. Phillips ERK, p38, and Smad Signaling Pathways Differentially Regulate Transforming Growth Factor-{beta}1 Autoinduction in Proximal Tubular Epithelial Cells Am. J. Pathol., October 1, 2006; 169(4): 1282 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Garcia-Donaire and L. M Ruilope Spotlight on Renin: Cardiovascular outcomes in chronic kidney disease and suppression of the renin-angiotensin system Journal of Renin-Angiotensin-Aldosterone System, March 1, 2006; 7(1): 56 - 58. [PDF]
|
|
|
|
|
|
X. L. Zhang, N. Topley, T. Ito, and A. Phillips Interleukin-6 Regulation of Transforming Growth Factor (TGF)-{beta} Receptor Compartmentalization and Turnover Enhances TGF-{beta}1 Signaling J. Biol. Chem., April 1, 2005; 280(13): 12239 - 12245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ito, J. D. Williams, D. J. Fraser, and A. O. Phillips Hyaluronan Regulates Transforming Growth Factor-{beta}1 Receptor Compartmentalization J. Biol. Chem., June 11, 2004; 279(24): 25326 - 25332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fraser, N. Brunskill, T. Ito, and A. Phillips Long-Term Exposure of Proximal Tubular Epithelial Cells to Glucose Induces Transforming Growth Factor-{beta}1 Synthesis via an Autocrine PDGF Loop Am. J. Pathol., December 1, 2003; 163(6): 2565 - 2574. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y.-C. Tian, D. Fraser, L. Attisano, and A. O. Phillips TGF-{beta}1-mediated alterations of renal proximal tubular epithelial cell phenotype Am J Physiol Renal Physiol, July 1, 2003; 285(1): F130 - F142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Tian and A. O. Phillips TGF-{beta}1-Mediated Inhibition of HK-2 Cell Migration J. Am. Soc. Nephrol., March 1, 2003; 14(3): 631 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Newton, S. C. Bevan, S. Choi, G. B. Robb, A. Millar, Y. Wang, and P. A. Marsden Translational Regulation of Human Neuronal Nitric-oxide Synthase by an Alternatively Spliced 5'-Untranslated Region Leader Exon J. Biol. Chem., January 3, 2003; 278(1): 636 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fraser, L. Wakefield, and A. Phillips Independent Regulation of Transforming Growth Factor-{beta}1 Transcription and Translation by Glucose and Platelet-Derived Growth Factor Am. J. Pathol., September 1, 2002; 161(3): 1039 - 1049. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
bars, n =
8), or in the presence of 10 nmol/L of
wortmannin
(
,
n = 5), 30 nmol/L of rapamycin
(
,
n = 8), or 2 µmol/L of PD
98059 (
, n =
4). Control experiments were performed by adding
5 mmol/L of D-glucose in the absence of insulin
(
,
n = 8). Supernatant samples were
collected at time points up to 48 hours for determination of TGF-ß1
by ELISA. Cell protein concentration of the remaining monolayer was
determined and results expressed as TGF-ß1 per ng of total cell
protein. Results represent mean ± SD; *, P <
0.05 versus the unstimulated control
(5 mmol/L D-glucose
alone).
